En Es
Categories

Industry News

Siemens Healthineers Strategy 2025 to Focus on AI

By Labmedica International staff writers
18 Jan 2018

Image: As part of its Strategy 2025, Siemens Healthineers plans to use data and AI to integrate existing and innovative technologies for therapy (Photo courtesy of iStock).Siemens Healthineers (Erlangen, Germany) has laid out its strategy to bolster its market leadership by 2025 and beyond, aimed at accelerating profitable growth and delivering return. The company has stated that it is well prepared to take advantage of the paradigm shift and structural growth opportunities in healthcare.

Siemens Healthineers estimates its core markets to grow by 3-5% annually on average from 2016 to 2021 to more than €50 billion per year, driven by growing and aging population, rise in chronic diseases, and improved access to healthcare in the emerging markets. With healthcare productivity historically lagging behind that of the other industries, the industry is witnessing horizontal and vertical consolidation, and governments and insurers are changing the financial incentive systems to transform healthcare delivery from volume to value. Additionally, medicine is becoming more precise and accessible, thereby empowering patients.

Digitalization and the use of artificial intelligence is further driving these changes in healthcare. Big data is becoming a source of value creation in the sector due to its abundant availability. Siemens Healthineers believes that it is well positioned to capitalize on the opportunities being created in the market due to its strong market position across the continuum of care. The company aims to drive profitable growth in its core business further and has a roadmap to its improve future profitability. Siemens Healthineers' Strategy 2025 is focused specifically on five future-oriented areas:

• Utilizing its unique position in the in-vivo and in-vitro markets to combine data and knowledge around precision medicine and make it relevant for clinical use

• Using data and artificial intelligence to integrate existing and innovative technologies for therapy

• Coordinating and optimizing the patient journey through the healthcare continuum

• Developing a full range of technical, operational and clinical service offerings that are more effective and more efficient by using technologies from Siemens Healthineers

• Continuing to develop and invest in capabilities in artificial intelligence that support the above areas

Siemens AG is preparing to list Siemens Healthineers on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market during the first half of calendar year 2018.

"It is a pleasure to talk about Siemens Healthineers, a business well prepared to take advantage of the paradigm shifts in healthcare," said Michael Sen. Chairman of the Supervisory Board of Siemens Healthineers and member of the Siemens Managing Board also responsible for the company's healthcare activities. "As a separate listed entity, Siemens Healthineers will have the entrepreneurial flexibility to actively shape its industry with a view to accelerating profitable growth and deliver return. It will also have direct access to the capital market, which will improve its ability to fund investment. Siemens will continue to actively support Siemens Healthineers as a majority shareholder."



E-mail Print
FaceBook Twitter Google+ Linked in

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for the medical industry
More info

More articles about Siemens Healthineers

14 May 2021
Siemens Launches its Fastest, Single-Source CT Scanner, Somatom X.ceed
Siemens Healthineers (Erlangen, Germany) has launched Somatom X.ceed, a new high-resolution, high-speed CT (computed tomography) scanner engineered specifically for the most challenging clinical areas where time and precision are of essence.
Read More
30 Apr 2021
Siemens Reportedly Considering Sale of Its Ultrasound Business
Siemens Healthineers (Erlangen, Germany) is considering selling off its ultrasound business and has also received expressions of interest in the business.
Read More
19 Apr 2021
Siemens Completes Acquisition of Varian to Create Integrated Portfolio of Imaging, Laboratory Diagnostics, AI and Cancer Treatment
Siemens Healthineers (Erlangen, Germany) has successfully completed the acquisition of Varian Medical Systems, Inc. (Palo Alto, CA, USA), thus strengthening its position as a holistic partner in healthcare.
Read More
04 Mar 2021
Siemens Partners with Epsilon Imaging on EchoInsight Analysis Software with Strain Imaging
Siemens Healthineers (Erlangen, Germany) has entered into a partnership with Epsilon Imaging (Ann Arbor, MI, USA) to offer syngo Dynamics users EchoInsight visualization and analysis with strain imaging.
Read More
03 Aug 2020
Siemens to Acquire Varian Medical to Create Comprehensive Cancer Portfolio
Siemens Healthineers (Erlangen, Germany) has entered into an agreement to acquire Varian Medical Systems, Inc. (Palo Alto, CA, USA) that will lead to the creation of a global leader in healthcare with a comprehensive portfolio to fight cancer.
Read More
15 Oct 2019
Siemens Healthineers’ AI-Based Chest CT Software Receives US FDA Clearance
The US Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent software assistant from Siemens Healthineers that brings artificial intelligence (AI) to computed tomography (CT).
Read More
13 Aug 2019
Siemens Healthineers' Acquires Corindus to Enhance Robotic-Assisted Interventions
Siemens Healthineers AG has entered into a merger agreement with Corindus Vascular Robotics, Inc. to acquire the company, which offers a robotic treatment platform for the major vascular therapeutic markets, including coronary, peripheral vascular and neurovascular interventions.
Read More
05 Aug 2019
Siemens Healthineers Receives Recognition AI Applications in Radiology
Based on its recent analysis of the global precision imaging market, Frost & Sullivan, a growth strategy consulting and research firm, has recognized Siemens Healthineers with the 2019 Global Visionary Innovation Leadership Award for leading the effort to establish imaging as an active contributor to precision medicine.
Read More

Additional news

25 Nov 2021
Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases
The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic cases, technological developments in point of care devices and increased investments by the key players.
Read More
24 Nov 2021
Euromedlab Congress 2021 Postponed as Fourth COVID-19 Wave Hits Germany
The XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab Congress 2021) to be held as an in-presence meeting between 28th of November and 2nd of December in Germany has been postponed as the country has been hit very hard by a fourth wave of COVID-19.
Read More
19 Nov 2021
44th World Hospital Congress (WHC) Ends on Upbeat Note as Hospital Leaders Look to Build Resilience
The 44th World Hospital Congress (WHC) organized by The International Hospital Federation (IHF; Geneva, Switzerland) on 8-11 November 2021 in Barcelona, Spain came to an upbeat close.
Read More
16 Nov 2021
Deborah Bowen (USA) Takes Up Position of IHF President for 2021-2023
Deborah Bowen has taken up the position of President of the International Hospital Federation (IHF; Geneva, Switzerland) following her election in 2019 and a two-year term as President Designate.
Read More
16 Nov 2021
IHF and Deloitte Collaborate to Launch Special Interest Group on Leadership for Sustainability
The International Hospital Federation (IHF; Geneva, Switzerland) will collaborate with Deloitte (London, UK) to launch a special interest group (SIG) centered around leadership for sustainability.
Read More
16 Nov 2021
International Hospital Federation (IHF) Announces Winners of IHF Awards 2021
The International Hospital Federation (IHF; Geneva, Switzerland) announced the winners of the IHF Awards 2021 as part of a special ceremony at the 44th World Hospital Congress (WHC) held in Barcelona, Spain.
Read More
13 Nov 2021
GE Healthcare to be Spun Off in 2023 to Create Pure-Play Company at Center of Precision Health
General Electric (GE; Boston, MA, USA) plans to pursue a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023.
Read More
11 Nov 2021
Blood Borne Testing Market to Witness Exponential Growth Due to Rising Incidence of Bacterial Infections
The global blood borne testing market is projected to record an exponential CAGR of over 7-8% during 2021-2031, driven by increasing bacterial infection and growing adoption of point of care devices, aided further by technological advancement in devices for blood borne pathogens. These are the latest findings of Fact.MR (Dublin, Ireland), a market research firm.
Read More
10 Nov 2021
AI in Radiology Market Driven by Growing Adoption of Machine Learning Tools in Broad Spectrum of Imaging Applications
The use of AI algorithms in medical image analysis field has made astounding progress. Particularly deep learning has made incessant inroads in radiology practice. The major consumer proposition for companies in the AI in radiology market stems from the exceptional capabilities of AI tools in recognizing complex patterns in the imaging data. These are the latest findings of Transparency Market Research (Albany NY, USA).
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions